VIRGINIA RETIREMENT SYSTEMS ET Al Takes $725,000 Position in DENTSPLY SIRONA Inc. $XRAY

Key Points

• The Virginia Retirement Systems acquired a new stake in DENTSPLY SIRONA Inc. worth approximately $725,000 by purchasing 45,634 shares.
• DENTSPLY SIRONA reported a quarterly earnings per share (EPS) of $0.52, exceeding expectations, but its revenue declined by 4.9% compared to the previous year.
• The company declared a quarterly dividend of $0.16, providing a 4.9% dividend yield for investors, despite a negative payout ratio of -13.50%.

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 45,634 shares of the medical instruments supplier's stock, valued at approximately $725,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Nordea Investment Management AB grew its holdings in DENTSPLY SIRONA by 71.0% during the second quarter. Nordea Investment Management AB now owns 428,015 shares of the medical instruments supplier's stock worth $6,853,000 after purchasing an additional 177,750 shares during the period. Allianz Asset Management GmbH grew its holdings in DENTSPLY SIRONA by 56.3% during the second quarter. Allianz Asset Management GmbH now owns 828,670 shares of the medical instruments supplier's stock worth $13,159,000 after purchasing an additional 298,413 shares during the period. NorthRock Partners LLC bought a new position in DENTSPLY SIRONA during the second quarter worth about $207,000. Envestnet Portfolio Solutions Inc. grew its holdings in DENTSPLY SIRONA by 36.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier's stock worth $246,000 after purchasing an additional 4,165 shares during the period. Finally, Sequoia Financial Advisors LLC grew its holdings in DENTSPLY SIRONA by 159.5% during the second quarter. Sequoia Financial Advisors LLC now owns 28,408 shares of the medical instruments supplier's stock worth $451,000 after purchasing an additional 17,461 shares during the period. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Down 0.4%

Shares of NASDAQ:XRAY opened at $13.11 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $11.69 and a 12-month high of $24.86. The stock has a market cap of $2.62 billion, a PE ratio of -2.77, a P/E/G ratio of 0.83 and a beta of 0.96. The business has a 50 day moving average of $13.35 and a 200-day moving average of $14.50. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA's payout ratio is -13.50%.

Wall Street Analyst Weigh In

XRAY has been the subject of a number of research analyst reports. Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a report on Friday, August 8th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Evercore ISI reduced their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating for the company in a report on Wednesday, October 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $18.00.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.